These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12376156)

  • 1. The effects of acute and subchronic treatment with fluoxetine and citalopram on stimulus control by DOM.
    Winter JC; Eckler JR; Doat MM; Rabin RA
    Pharmacol Biochem Behav; 2002 Dec; 74(1):95-101. PubMed ID: 12376156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of DOM-induced stimulus control by fluoxetine and citalopram: role of pharmacokinetics.
    Eckler JR; Doat MM; Rabin RA; Winter JC
    Life Sci; 2002 Aug; 71(11):1341-7. PubMed ID: 12106599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 5-HT(2C) receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat.
    Eckler JR; Reissig CJ; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2004 Sep; 79(1):25-30. PubMed ID: 15388280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonergic/glutamatergic interactions: potentiation of phencyclidine-induced stimulus control by citalopram.
    Winter JC; Eckler JR; Rice KC; Rabin RA
    Pharmacol Biochem Behav; 2005 Jul; 81(3):694-700. PubMed ID: 15970314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The acute effects of monoamine reuptake inhibitors on the stimulus effects of hallucinogens.
    Winter JC; Helsley S; Fiorella D; Rabin RA
    Pharmacol Biochem Behav; 1999 Jul; 63(3):507-13. PubMed ID: 10418794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors potentiate 8-OH-DPAT-induced stimulus control in the pigeon.
    Wolff MC; Leander JD
    Eur J Pharmacol; 1998 Mar; 345(1):35-9. PubMed ID: 9593591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nefazodone in the rat: mimicry and antagonism of [-]-DOM-induced stimulus control.
    Eckler JR; Rabin RA; Winter JC
    Pharmacol Biochem Behav; 2003 May; 75(2):405-10. PubMed ID: 12873632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
    Winter JC; Filipink RA; Timineri D; Helsley SE; Rabin RA
    Pharmacol Biochem Behav; 2000 Jan; 65(1):75-82. PubMed ID: 10638639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of clozapine and 2,5-dimethoxy-4-methylamphetamine [DOM] on 5-HT2A receptor expression in discrete brain areas.
    Doat-Meyerhoefer MM; Hard R; Winter JC; Rabin RA
    Pharmacol Biochem Behav; 2005 Aug; 81(4):750-7. PubMed ID: 15972234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further investigations of the interactions of antipsychotics with the (-)2,5-dimethoxy-4-methylamphetamine (DOM) discriminative stimulus.
    Fiorella D; Helsley S; Rabin RA; Winter JC
    Neuropharmacology; 1997 Oct; 36(10):1463-9. PubMed ID: 9423935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The time-dependent stimulus effects of R(-)-2,5-dimethoxy-4-methamphetamine (DOM): implications for drug-induced stimulus control as a method for the study of hallucinogenic agents.
    Fiorella D; Palumbo PA; Rabin RA; Winter JC
    Psychopharmacology (Berl); 1995 May; 119(2):239-45. PubMed ID: 7659772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate].
    Muraki I
    Hokkaido Igaku Zasshi; 2001 Mar; 76(2):57-70. PubMed ID: 11344903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents.
    Marona-Lewicka D; Nichols DE
    Psychopharmacology (Berl); 1998 Jul; 138(1):67-75. PubMed ID: 9694528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
    Li JX; Unzeitig A; Javors MA; Rice KC; Koek W; France CP
    J Pharmacol Exp Ther; 2009 Nov; 331(2):671-9. PubMed ID: 19687292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
    Fletcher PJ; Sinyard J; Salsali M; Baker GB
    Psychopharmacology (Berl); 2004 Jul; 174(3):406-13. PubMed ID: 14740149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin 5-HT2C receptor-mediated phosphoinositide hydrolysis in rat choroid plexus after fluoxetine and citalopram treatments.
    Pälvimäki EP; Majasuo H; Syvälahti E; Hietala J
    Pharmacol Res; 2005 May; 51(5):419-25. PubMed ID: 15749456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys: antagonism and apparent pA2 analyses.
    Li JX; Rice KC; France CP
    J Pharmacol Exp Ther; 2009 Mar; 328(3):976-81. PubMed ID: 19098164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus.
    Laakso A; Pälvimäki EP; Kuoppamäki M; Syvälahti E; Hietala J
    Neuropsychopharmacology; 1996 Aug; 15(2):143-51. PubMed ID: 8840350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for accelerated desensitisation of 5-HT(2C) receptors following combined treatment with fluoxetine and the 5-HT(1A) receptor antagonist, WAY 100,635, in the rat.
    Bristow LJ; O'Connor D; Watts R; Duxon MS; Hutson PH
    Neuropharmacology; 2000 Apr; 39(7):1222-36. PubMed ID: 10760364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of cycling female rats with fluoxetine induces desensitization of hypothalamic 5-HT(1A) receptors with no change in 5-HT(2A) receptors.
    Van de Kar LD; Raap DK; Battaglia G; Muma NA; Garcia F; DonCarlos LL
    Neuropharmacology; 2002 Jul; 43(1):45-54. PubMed ID: 12213258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.